The pathology of cervical tumours

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 19, Issue 4 SPEC. ISS., 2005, Pages 485-500

  Tiltman, A J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Carcinoma cervix; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; VASCULOTROPIN;

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOSQUAMOUS CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SIZE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 24644461661     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2005.02.003     Document Type: Review

References (94)

1. F.A. Tavassoli & P. Devilee (eds.) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs 2003 IARC Press Lyon
2. J. Albores-Saavedra D. Gersell C.B. Gilks et al. Terminology of endocrine tumors of the uterine cervix: Results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute Arch Pathol Lab Med 121 1997 34-39
3. W.J. van Driel P. Kievit-Tyson L.C. van den Broek et al. Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response Gynecol Oncol 74 1999 188-195
4. G.W. Spiegel M. Ashraf & J.J. Brooks Eosinophils as a marker for invasion in cervical squamous neoplastic lesions Int J Gynecol Pathol 21 2002 117-124
5. FIGO Committee on Gynecologic Oncology Staging classifications and clinical practice guidelines of gynecologic cancers Int J Gynecol Obstet 70 2000 207-312
6. A.G. Östör Natural history of cervical intraepithelial neoplasia: A critical review Int J Gynecol Pathol 12 1993 186-192
7. W.A. McIndoe M.A. McClean R.W. Jones & P.R. Mullins The invasive potential of carcinoma in situ of the cervix Obstet Gynecol 64 1984 451-454
8. K. Kurian & A. al-Nafussi Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: A study of 121 cases J Clin Pathol 52 1999 112-117
9. S.C. Plaxe & S.L. Saltzstein Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening Gynecol Oncol 75 1999 55-61
10. M.E. Boon J.P. Baak P.J. Kurver et al. Adenocarcinoma in situ of the cervix: An underdiagnosed lesion Cancer 48 1981 768-773
11. M. Kashimura M. Shinohara K. Oikawa et al. An adenocarcinoma in situ of the uterine cervix that developed into invasive adenocarcinoma after 5 years Gynecol Oncol 36 1990 128-133
12. O.B. Ioffe S. Sagae S. Moritani et al. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions 'less than' adenocarcinoma in situ? Point Int J Gynecol Pathol 22 2003 18-21
13. K.R. Lee Symposium part 4: Should pathologists diagnose endocervical preneoplastic lesions 'less than' adenocarcinoma in situ? Counterpoint Int J Gynecol Pathol 22 2003 22-24
14. O.B. Ioffe S. Sagae S. Moritani et al. Proposal of a new scoring scheme for the diagnosis of noninvasive endocervical glandular lesions Am J Surg Pathol 27 2003 452-460
15. A.G. Östör Early invasive adenocarcinoma of the uterine cervix Int J Gynecol Pathol 19 2000 29-38
16. W. Grayson L.F. Taylor & K. Cooper Adenoid cystic and adenoid basal carcinoma of the uterine cervix: A comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin Am J Surg Pathol 23 1999 448-458
17. W. Grayson L. Taylor & K. Cooper Detection of integrated high risk human papillomavirus in adenoid cystic carcinoma of the uterine cervix J Clin Pathol 49 1996 805-809
18. W. Grayson L.F. Taylor & K. Cooper Adenoid basal carcinoma of the uterine cervix: Detection of integrated human papillomavirus in a rare tumour of putative 'reserve cell' origin Int J Gynecol Pathol 16 1997 299-300
19. M.W. Jones S. Kounelis H. Papadaki et al. The origin and molecular characterization of adenoid basal carcinoma of the uterine cervix Int J Gynecol Pathol 16 1997 301-306
20. R.E. Scully P. Aguirre & R.A. DeLellis Argyophilia, serotonin and peptide hormones in the female genital tract and its tumors Int J Gynecol Pathol 3 1984 51-70
21. F. Fetissof G. Serres B. Arbeille et al. Argyrophilic cells and ectocervical epithelium Int J Gynecol Pathol 10 1991 177-190
22. W. Grayson H.A. Rhemtula L.F. Taylor et al. Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: A study of 12 cases J Clin Pathol 55 2002 108-114
23. N. Sakuragi C. Satoh N. Takeda et al. Incidence and distribution pattern of pelvic and para-aortic lymph node metastases in patients with stages IB, IIA and IIB cervical carcinoma treated with radical hysterectomy Cancer 85 1999 1547-1554
24. K.S. Metcalf N. Johnson S. Calvert & K.R. Peel Site specific lymph node metastases in carcinoma of the cervix; is there a sentinal node? Int J Gynecol Cancer 10 2000 411-416
25. P.J. Eifel M. Morris M.J. Oswald et al. Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases Cancer 65 1990 2507-2514
26. A. Leminen J. Paavonen M. Forss et al. Adenocarcinoma of the uterine cervix Cancer 65 1990 53-59
27. G.B. Kristensen V.M. Abeler B. Risberg et al. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma Gynecol Oncol 74 1999 245-251
28. G. Delgado B. Bundy R. Zaino et al. Prospective surgical-pathological study of disease free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study Gynecol Oncol 38 1990 352-357
29. R.D. Alvarez M.E. Potter S.J. Soong et al. Rationale for using tumor dimensions and nodal status to subclassifiy surgically treated stage IB cervical cancer patients Gynecol Oncol 43 1991 108-112
30. M.P. Hopkins & G.W. Morley Stage IB squamous cell carcinoma of the cervix: Clinicopathlogical features related to survival Am J Obstet Gynecol 164 1991 1520-1527
31. H. Ishikawa T. Nakanishi T. Inoue & K. Kuzuya Prognostic factors of adenocarcinoma of the uterine cervix Gynecol Oncol 73 1999 42-46
32. P. Morice P. Piovesan A. Rey et al. Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: Results of a multivariate analysis Ann Oncol 14 2003 1511-1517
33. P.W. Grigsby C.A. Perez R.R. Kuske et al. Adenocarcinoma of the uterine cervix: Lack of evidence for a poor prognosis Radiother Oncol 12 1988 289-296
34. J.S. Berek N.F. Hacker Y.S. Fu et al. Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival Obstet Gynecol 65 1985 46-52
35. T. Inoue Prognostic significance of the depth of invasion relating to nodal metastases, parametrial extension and cell types. A study of 628 cases with stage IB, IIA and IIB cervical carcinoma Cancer 54 1984 3035-3042
36. S.L. Buckley D.M. Tritz L. van Le Lymph et al. node metastases and prognosis in patients with stage IA cervical cancer Gynecol Oncol 63 1996 4-9
37. K. Hasumi A. Sakamoto & H. Sugano Microinvasive carcinoma of the uterine cervix Cancer 45 1980 928-931
38. N. Takeshima K. Yanoh T. Tabata et al. Assessment of the revised International Federation of Gynecology and Obstetrics staging for early invasive squamous cervical carcinoma Gynecol Oncol 74 1999 165-169
39. N. Takeda N. Sakuragi M. Takeda et al. Multivariate analysis of histopathological prognostic factors in invasive cervical carcinoma treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy Acta Obstet Gynecol Scand 81 2002 1144-1151
40. W.T. Creasman & M.F. Kohler Is lymph vascular space involvement an independent prognostic factor in early cervical cancer? Gynecol Oncol 92 2004 525-529
41. P. Sykes D. Allen C. Cohen et al. Does the density of lymphatic vascular space invasion affect prognosis of stage Ib and IIa node negative carcinoma of the cervix Int J Gynecol Cancer 13 2003 313-316
42. S. Memarzadeh S. Natarajan D.P. Dandale et al. Lymphvascular and perineural invasion in the parametria: Prognostic factor for early-stage cervical cancer Obstet Gynecol 102 2003 612-619
43. M.E. Randall W.C. Constable S.S. Hahn et al. Results of the radiotherapeutic management of carcinoma of the cervix with emphasis on the influence of histologic classification Cancer 62 1988 48-53
44. M. Stockler P. Russell S. McGahan et al. Prognosis and prognostic factors in node negative cervix cancer Int J Gynecol Oncol 6 1996 477-482
45. R.J. Zaino S. Ward G. Delgado et al. Histopathological predictors of the behaviour of surgically treated stage IB squamous cell carcinoma of the cervix Cancer 69 1992 1750-1758
46. M.L. Davy T.J. Dodd C.G. Luke & D.M. Roder Cervical cancer: Effect of glandular cell type on prognosis, treatment and survival Obstet Gynecol 101 2003 38-45
47. M.P. Hopkins & G.W. Morley A comparison of adenocarcinoma and squamous cell carcinoma of the cervix Obstet Gynecol 77 1991 912-917
48. R.J. Chen Y.H. Lin C.A. Chen et al. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan Gynecol Oncol 73 1999 184-190
49. W. Kleine K. Rau D. Schwoeorer & A. Pfleiderer Prognosis of adenocarcinoma of the cervix uteri: A comparative study Gynecol Oncol 35 1989 145-149
50. I. Milsom & L.G. Friberg Primary adenocarcinoma of the uterine cervix. A clinical study Cancer 52 1983 942-947
51. A. Ayhan R.A. Al C. Baykal et al. A comparison of prognosis of FIGO stage IB adenocarcinoma and squamous cell carcinoma Int J Gynecol Cancer 14 2004 279-285
52. H.M. Shingleton M.C. Bell A. Fremgen et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma of the cervix? Cancer 76 1995 1948-1955
53. D. Grisaru A. Covens B. Chapman et al. Does histology influence prognosis in patients with early stage cervical carcinoma? Cancer 92 2001 2999-3004
54. C.B. Gilks & P.B. Clement Papillary serous adenocarcinoma of the uterine cervix: Report of three cases Mod Pathol 5 1992 426-431
55. P.G. Rose & F.R. Real Serous papillary carcinoma of the cervix Gynecol Oncol 50 1993 361-364
56. K.Y. Look V.L. Brunetto D.L. Clarke-Pearson et al. An analysis of cell type in patients with surgically staged IB carcinoma of the cervix: A Gynecologic Oncology Group study Gynecol Oncol 63 1996 304-311
57. J.S. Lea R.L. Coleman E.O. Garner et al. Adenosquamous histology predicts poor outcome in low risk stage IB1 cervical adenocarcinoma Gynecol Oncol 91 2003 558-562
58. G.C. Alfsen W. Reed & V.M. Abeler Reproducibility of classification in non-squamous cell carcinomas of the uterine cervix Gynecol Oncol 90 2003 282-289
59. M.P. Hopkins & G.W. Morley Glassy cell adenocarcinoma of the uterine cervix Am J Obstet Gynecol 190 2004 67-70
60. H.J. Gray R. Garcia H.K. Tamini et al. Glassy cell carcinoma of the cervix revisited Gynecol Oncol 85 2002 274-277
61. M.G. Conner H. Richter C.A. Moran et al. Small cell carcinoma of the cervix: A clinicopathologic and immunohistochemical study of 23 cases Ann Diagn Pathol 6 2002 345-348
62. J.K. Chan V. Loizzi R.A. Burger et al. Prognostic factors in neuroendocrine small cell cervical carcinoma: A multivariate analysis Cancer 97 2003 568-574
63. A.N. Viswanathan M.T. Deavers A. Jhingran et al. Small cell neuroendocrine carcinoma of the cervix: Outcome and patterns of recurrence Gynecol Oncol 93 2004 27-33
64. C.B. Gilks R.H. Young D.J. Gersell & P.B. Clement Large cell neuroendocrine (corrected) carcinoma of the uterine cervix: A clinicopathologic study of 12 cases Am J Surg Pathol 21 1997 905-914
65. H. Rhemtula W. Grayson B. van Iddekinge & A. Tiltman Large cell neuroendocrine carcinoma of the uterine cervix - a clinicopathological study of five cases S Afr Med J 91 2001 525-528
66. Y. Sato T. Shimamoto S. Amada et al. Large cell neuroendocrine carcinoma of the uterine cervix: A clinico pathological study of six cases Int J Gynecol Pathol 22 2003 226-230
67. H.M. Goodman C.A. Buttlar J.M. Niloff et al. Adenocarcinoma of the uterine cervix: Prognostic factors and patterns of recurrence Gynecol Oncol 33 1989 241-247
68. U. Stendahl H. Willen & R. Willen Invasive squamous cell carcinoma of the uterine cervix. I. Definition of parameters in a histopathologic malignancy grading system Acta Radiol Oncol 19 1980 467-480
69. R.J. Stock R. Zaino B.N. Bundy et al. Evaluation and comparison of histologic grading systems of epithelial carcinomas of the uterine cervix: Gynecologic Oncology Group studies Int J Gynecol Pathol 13 1994 99-108
70. J.D. Crissman M. Budhraja B.S. Aron & G. Cummings Histopathologic prognostic factors in stage II and III squamous cell carcinoma of the uterine cervix. An evaluation of 91 patients treated primarily with radiation therapy Int J Gynecol Pathol 6 1987 97-103
71. S. Ozalp O.T. Yalcin U. Oner et al. Microvessel density as a prognostic factor in preinvasive and invasive cervical lesions Eur J Gynaecol Oncol 24 2003 425-428
72. K. Tokumo J. Kodama N. Seki et al. Different angiogenic pathways in human cervical cancers Gynecol Oncol 68 1998 38-44
73. G.L. Bremer A.T. Tiebosch H.W. van der Putten et al. Tumor angiogenesis: an independent prognostic parameter in cervical cancer Am J Obstet Gynecol 174 1996 126-131
74. A. Obermair C. Wanner S. Bilgi et al. Tumour angiogenesis in stage IB cervical cancer: correlation of microvessel density with survival Am J Obstet Gynecol 178 1998 314-319
75. D. Cantu De Leon C. Lopez-Graniel M. Fias Mendivil et al. Significance of microveascular density (MVD) in cervical cancer recurrence Int J Gynecol Cancer 13 2003 856-862
76. T. Kaku T. Hirakawa T. Kamura et al. Angiogenesis in adenocarcinoma of the uterine cervix Cancer 83 1998 1384-1390
77. C. Kainz P. Speiser C. Wanner et al. Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB to IIB Anticancer Res 15 1995 1549-1551
78. J.L. Rutgers T.F. Mattox & M.P. Vargas Angiogenesis in uterine cervical squamous cell carcinomas Int J Gynecol Pathol 14 1995 114-118
79. W.F. Cheng C.A. Chen C.N. Lee et al. Vascular endoethelial growth factor and prognosis of cervical carcinoma Obstet Gynecol 96 2000 721-726
80. J.A. Loncaster R.A. Cooper J.P. Logue et al. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix Br J Cancer 83 2000 620-625
81. D.K. Gaffney D. Haslam A. Tsodikov et al. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy Int J Radiat Oncol Biol Phys 15 2003 922-928
82. A.D. Santin P.L. Hermonat A. Ravaggi et al. Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix Obstet Gynecol 94 1999 78-82
83. I.J. Lee K.R. Park K.K. Lee et al. Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 54 2002 768-779
84. S. Masood R.M. Rhatigan E.W. Wilkinson et al. Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix: An immunocytochemical study Cancer 72 1993 511-518
85. H. Fujiwara G. Tortolero-Luna M.F. Mitchell et al. Adenocarcinoma of the cervix. Expression and clinical significance of oestrogen and progesterone receptors Cancer 79 1997 505-512
86. Y. Suzuki T. Nakano T. Arai et al. Progesterone receptor is a favourable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix Int J Radiat Oncol Biol Phys 47 2000 1229-1234
87. H.Y. Chen C.T. Hsu W.C. Lin et al. Prognostic value of p53 expression in stage IB1 cervical carcinoma Gynecol Obstet Invest 49 2000 266-271
88. S.M. Brenna L.C. Zeferino G.A. Pinto et al. p53 expression as a predictor of recurrence in cervical squamous carcinoma Int J Gynecol Cancer 12 2002 299-303
89. D. Jain R. Srinivasan F.D. Patel & S. Kumari Gupta Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIB/III patients treated by radiotherapy Gynecol Oncol 88 2003 22-28
90. G. van de Putte R. Holm A.K. Lie et al. Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis Gynecol Oncol 89 2003 140-147
91. G.C. Alfsen W. Reed B. Sandstad et al. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1 and p16INK4/MTS1 in adenocarcinoma of the uterine cervix: An immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma Cancer 98 2003 1880-1889
92. D.M. Ho C.Y. Hsu & H. Chiang MIB-1 labelling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix Gynecol Oncol 76 2000 97-102
93. M. Graflund B. Sorbe M. Bryne & M. Karlsson The prognostic value of a histologic grading system, DNA profile and MIB-1 expression in early stages of cervical squamous cell carcinoma Int J Gynecol Cancer 12 2002 149-157
94. T.W. Leung W.C. Xue A.N. Cheung et al. Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix Gynecol Oncol 92 2004 866-872